1. Tang S, Shu X. [Effect of CCR3 gene on related inflammatory cells in respiratory allergic diseases]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Jan 5;35(1):80-84. Chinese. doi: 10.13201/j.issn.2096-7993.2021.01.021. PMID: 33540982; PMCID: PMC10128548.
2. Gangur V, Birmingham NP, Thanesvorakul S, Joseph S. CCR3 and CXCR3 as drug targets for allergy: principles and potential. Curr Drug Targets Inflamm Allergy. 2003 Mar;2(1):53-62. doi: 10.2174/1568010033344453. PMID: 14561176.
3. Rosendahl S, Sulniute R, Persson J, Forsberg S, Häggvik R, Drewsen V, Koskinen Holm C, Kindstedt E, Lundberg P. Lack of CCR3 leads to a skeletal phenotype only in male mice. Biochem Biophys Res Commun. 2022 Sep 10;620:98-104. doi: 10.1016/j.bbrc.2022.06.062. Epub 2022 Jun 24. PMID: 35780587.
4. Amerio P, Frezzolini A, Feliciani C, Verdolini R, Teofoli P, De Pità O, Puddu P. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications. Curr Drug Targets Inflamm Allergy. 2003 Mar;2(1):81-94. doi: 10.2174/1568010033344480. PMID: 14561178.